A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023.
Saved in:
| Title: | A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023. |
|---|---|
| Authors: | Jallorina A; California University of Science and Medicine, Colton, CA., Vij K; West Virginia School of Osteopathic Medicine, Lewisburg, WV., Wan L; West Virginia School of Osteopathic Medicine, Lewisburg, WV., Thomas J; West Virginia School of Osteopathic Medicine, Lewisburg, WV., Drum D; California University of Science and Medicine, Colton, CA., Glick SA; SUNY Downstate Health Sciences University, Department of Dermatology, Brooklyn, NY.; Maimonides Medical Center, Department of Medicine, Brooklyn, NY., Lee-Wong MF; Icahn School of Medicine at Mount Sinai, Division of Allergy and Clinical Immunology, Department of Medicine, New York, NY; and.; Maimonides Medical Center, Department of Medicine, Brooklyn, NY. |
| Source: | Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2025 Feb 01; Vol. 85 (2), pp. 97-107. Date of Electronic Publication: 2025 Feb 01. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Electronic Cited Medium: Internet ISSN: 1533-4023 (Electronic) Linking ISSN: 01602446 NLM ISO Abbreviation: J Cardiovasc Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1533-4023 |
|---|---|
| DOI: | 10.1097/FJC.0000000000001660 |
